Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (21)

2023

  1. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

2022

  1. Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

    Cancers, Vol. 14, Núm. 12

2021

  1. Lipid alterations in human frontal cortex in ALS-FTLD-TDP43 proteinopathy spectrum are partly related to peroxisome impairment

    Neuropathology and Applied Neurobiology, Vol. 47, Núm. 4, pp. 544-563

  2. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

    Brain Communications, Vol. 3, Núm. 3

  3. Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study

    Journal of Neurochemistry, Vol. 158, Núm. 2, pp. 482-499

  4. Obesity-associated deficits in inhibitory control are phenocopied to mice through gut microbiota changes in one-carbon and aromatic amino acids metabolic pathways

    Gut, Vol. 70, Núm. 12, pp. 2283-2296

2020

  1. Obesity Impairs Short-Term and Working Memory through Gut Microbial Metabolism of Aromatic Amino Acids

    Cell Metabolism, Vol. 32, Núm. 4, pp. 548-560.e7

  2. Succination of Protein Thiols in Human Brain Aging

    Frontiers in Aging Neuroscience, Vol. 12

2018

  1. Regional vulnerability to lipoxidative damage and inflammation in normal human brain aging

    Experimental Gerontology, Vol. 111, pp. 218-228

2017

  1. Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1862, Núm. 5, pp. 485-495

  2. Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients

    Oncotarget, Vol. 8, Núm. 65, pp. 109018-109026

2016

  1. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis

    Neurobiology of Disease, Vol. 88, pp. 148-160

2015

  1. Altered glycolipid and glycerophospholipid signaling drive inflammatory cascades in adrenomyeloneuropathy

    Human Molecular Genetics, Vol. 24, Núm. 24, pp. 6861-6876

  2. Deregulation of purine metabolism in Alzheimer's disease

    Neurobiology of Aging, Vol. 36, Núm. 1, pp. 68-80

  3. Lipidomics of Human Brain Aging and Alzheimer's Disease Pathology

    International Review of Neurobiology (Academic Press Inc.), pp. 133-189

2014

  1. Metabolomics of human brain aging and age-related neurodegenerative diseases

    Journal of Neuropathology and Experimental Neurology, Vol. 73, Núm. 7, pp. 640-657

2013

  1. Estudio de la vulnerabilidad neuronal selectiva en el sistema nervioso central humano

    Revista Espanola de Geriatria y Gerontologia, Vol. 48, Núm. 5, pp. 216-223

2011

  1. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy

    Annals of Neurology, Vol. 70, Núm. 1, pp. 84-92

  2. Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy

    Antioxidants and Redox Signaling, Vol. 15, Núm. 8, pp. 2095-2107

2008

  1. Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy

    Human Molecular Genetics, Vol. 17, Núm. 12, pp. 1762-1773